Robert E. Gerberich
Plus aucun poste en cours
Profil
Robert E.
Gerberich held several positions in sales and marketing, including Vice President of Sales & Marketing at Invuity, Inc. and Head of North American Sales at Inamed Aesthetics.
He also served as President of Ultrashape Na, Inc. from 2006 to 2012.
Gerberich's education includes an undergraduate degree from Illinois State University.
Anciens postes connus de Robert E. Gerberich
| Sociétés | Poste | Fin |
|---|---|---|
| INVUITY INC | Corporate Officer/Principal | 01/03/2017 |
| Ultrashape Na, Inc. | President | 01/04/2012 |
| CAESARS ENTERTAINMENT, INC. | Corporate Officer/Principal | - |
UltraShape Ltd.
 UltraShape Ltd. Medical SpecialtiesHealth Technology UltraShape redefines aesthetic medicine by developing, manufacturing and marketing innovative non-invasive technologies for fat cell destruction and body sculpting. The company develops and markets clinically proven safe and effective solutions that enhance the lives of patients. The UltraShape proprietary technology employs pulsed (non-thermal) focused ultrasound that instantly, selectively and permanently destroys fat cells without affecting surrounding structures. Founded in 2000, UltraShape has sold Contour I devices in more than 50 countries, demonstrating safety and efficacy. The UltraShape Contour I system, is authorized for marketing outside the U.S. It is the first clinically proven non-invasive solution that offers measurable lasting body sculpting results for men and women with no need for maintenance treatments. The UltraShape system has been shown to be safe and effective in a multi-center controlled trial and numerous other peer-reviewed published independent clinical studies. The device is designed to produce mechanical, non-thermal, acoustic effects which target and selectively destroy (breakdown) fat cells, leaving surrounding critical structures such as skin, blood vessels, nerves, and connective tissue intact. The latest Contour I V3 system uses Vertical Dynamic Focus™ (VDF) pulsed (non-thermal) focused ultrasound that instantly and permanently destroys fat cells providing patients a convenient noninvasive no-downtime solution to reduce localized fat deposits and body circumference. The UltraShape procedure is based on a natural fat clearance process where triglycerides and cell debris from the destroyed fat cells are processed by the body's natural physiological and metabolic pathways. These pathways are the same that handle fat during weight loss. Results from UltraShape's peer-reviewed published multi-center controlled clinical trial and other independent clinical studies show that the released triglycerides do not accumulate to a clinically significant extent in the blood or liver. Over 200,000 patient treatments have been performed worldwide with the Contour I showing high patient satisfaction while demonstrating safety and efficacy. The UltraShape procedure is guided by proprietary real-time tracking and guidance technology designed to deliver smooth, uniform body contouring results. The software guides the operator through a pres-determined treatment algorithm designed to minimize risk of contour irregularities, a common side effect of invasive and non-invasive procedures. The UltraShape procedure is performed during a convenient, 'walk-in, walk-out' session carried out in an office-based environment; it requires no anesthesia or sedation. After treatment, patients immediately resume their daily routines with no need for maintenance treatments. The UltraShape Contour I received the CE Mark in 2005 and a medical device license from Health Canada in 2007. The Contour I system is not available for sale in the U.S; the Contour Plus system is an investigational product limited by U.S. law to investigational use only. | Corporate Officer/Principal | - |
| Leibinger LP | Corporate Officer/Principal | - |
Formation de Robert E. Gerberich
| Illinois State University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Mentor Worldwide LLC
 Mentor Worldwide LLC Medical SpecialtiesHealth Technology Mentor Worldwide LLC develops, manufactures and markets science-based products. It offers surgical and non-surgical medical procedures such as breast implants, skin and tissue expanders and facial and dermal implants. The company was founded by Christopher J. Conway in 1969 and is headquartered in Irvine, CA. | Health Technology |
Invuity, Inc.
 Invuity, Inc. Medical DistributorsDistribution Services Invuity, Inc. operates as a medical technology company. The firm engages in the development and marketing of surgical and medical devices. Its products include retractors, handhelds and drop-ins under the Photonics and PhotonBlade brands. The company was founded by Kenneth B. Trauner and Alex Vayser on November 29, 2004 and is headquartered in San Francisco, CA. | Distribution Services |
Thermage, Inc.
 Thermage, Inc. Medical SpecialtiesHealth Technology Thermage, Inc. manufactures and distributes medical devices. The company is developing innovative aesthetic technologies including its patented capacitive radiofrequency device to achieve a desired cosmetic or therapeutic effecton and under the skin surface. The company was founded in the year 1995 by Edward W. Knowlton and is headquartered in Hayward, CA. | Health Technology |
| Inamed Aesthetics | |
UltraShape Ltd.
UltraShape Ltd. Medical SpecialtiesHealth Technology UltraShape redefines aesthetic medicine by developing, manufacturing and marketing innovative non-invasive technologies for fat cell destruction and body sculpting. The company develops and markets clinically proven safe and effective solutions that enhance the lives of patients. The UltraShape proprietary technology employs pulsed (non-thermal) focused ultrasound that instantly, selectively and permanently destroys fat cells without affecting surrounding structures. Founded in 2000, UltraShape has sold Contour I devices in more than 50 countries, demonstrating safety and efficacy. The UltraShape Contour I system, is authorized for marketing outside the U.S. It is the first clinically proven non-invasive solution that offers measurable lasting body sculpting results for men and women with no need for maintenance treatments. The UltraShape system has been shown to be safe and effective in a multi-center controlled trial and numerous other peer-reviewed published independent clinical studies. The device is designed to produce mechanical, non-thermal, acoustic effects which target and selectively destroy (breakdown) fat cells, leaving surrounding critical structures such as skin, blood vessels, nerves, and connective tissue intact. The latest Contour I V3 system uses Vertical Dynamic Focus™ (VDF) pulsed (non-thermal) focused ultrasound that instantly and permanently destroys fat cells providing patients a convenient noninvasive no-downtime solution to reduce localized fat deposits and body circumference. The UltraShape procedure is based on a natural fat clearance process where triglycerides and cell debris from the destroyed fat cells are processed by the body's natural physiological and metabolic pathways. These pathways are the same that handle fat during weight loss. Results from UltraShape's peer-reviewed published multi-center controlled clinical trial and other independent clinical studies show that the released triglycerides do not accumulate to a clinically significant extent in the blood or liver. Over 200,000 patient treatments have been performed worldwide with the Contour I showing high patient satisfaction while demonstrating safety and efficacy. The UltraShape procedure is guided by proprietary real-time tracking and guidance technology designed to deliver smooth, uniform body contouring results. The software guides the operator through a pres-determined treatment algorithm designed to minimize risk of contour irregularities, a common side effect of invasive and non-invasive procedures. The UltraShape procedure is performed during a convenient, 'walk-in, walk-out' session carried out in an office-based environment; it requires no anesthesia or sedation. After treatment, patients immediately resume their daily routines with no need for maintenance treatments. The UltraShape Contour I received the CE Mark in 2005 and a medical device license from Health Canada in 2007. The Contour I system is not available for sale in the U.S; the Contour Plus system is an investigational product limited by U.S. law to investigational use only. | Health Technology |
| Ultrashape Na, Inc. | |
| Leibinger LP | |
Caesars Holdings, Inc.
 Caesars Holdings, Inc. Hotels/Resorts/Cruise linesConsumer Services Caesars Holdings, Inc. is a holding company, which engages in the provision of casino-entertainment and hospitality services. It operates through the following segments: Las Vegas, Other U.S., and All Other. The All Other segment includes managed and international properties as well as other business, such as Caesars Interactive Entertainment. Its brands include Aesars, Harrahs, Horseshoe, Wsop, Linq, Caesars, and Paris. The company was founded by William Fisk Harrah in 1937 and is headquartered in Las Vegas, NV. | Consumer Services |
Primcogent Solutions LLC
 Primcogent Solutions LLC Medical SpecialtiesHealth Technology Primcogent Solutions LLC manufactures and sells medical equipment. The company is headquartered in Dallas, TX. | Health Technology |